Canada Pension Plan Investment Board Acadia Pharmaceuticals Inc Transaction History

Canada Pension Plan Investment Board

$97.2 Billion
Q4 2024

A detailed history of Canada Pension Plan Investment Board transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 780,700 shares of ACAD stock, worth $14.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

780,700

Previous 651,100 19.9%

Holding current value

$14.1 Million

Previous $10 Million 42.96%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $1.85 Million - $2.43 Million	129,600 Added 19.9%	780,700 $14.3 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $1.33 Million - $1.68 Million	-87,600 Reduced 11.86%	651,100 $10 Million
Q2 2024 Aug 12, 2024	BUY	$14.62 - $18.42 $1.13 Million - $1.42 Million	77,100 Added 11.65%	738,700 $12 Million
Q1 2024 May 14, 2024	BUY	$17.79 - $30.86 $11.8 Million - $20.4 Million	661,600 New	661,600 $12.2 Million
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $89,769 - $187,818	6,900 Added 12.11%	63,900 $900,000
Q1 2022 May 13, 2022	BUY	$20.94 - $27.5 $1.19 Million - $1.57 Million	57,000 New	57,000 $1.38 Million
Q4 2020 Feb 17, 2021	SELL	$41.04 - $56.79 $144,707 - $200,241	-3,526 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $1.04 Million - $1.63 Million	-28,554 Reduced 89.01%	3,526 $145,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $851,156 - $1.14 Million	21,680 Added 208.46%	32,080 $1.56 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $263,707 - $390,520	-8,332 Reduced 44.48%	10,400 $439,000
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $122,932 - $174,503	3,395 Added 22.14%	18,732 $801,000
Q3 2019 Nov 12, 2019	SELL	$22.22 - $44.01 $254,618 - $504,310	-11,459 Reduced 42.76%	15,337 $552,000
Q2 2019 Aug 12, 2019	SELL	$23.32 - $28.12 $1.62 Million - $1.96 Million	-69,604 Reduced 72.2%	26,796 $716,000
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $14,553 - $24,642	-900 Reduced 0.92%	96,400 $2.59 Million
Q4 2018 Feb 06, 2019	BUY	$14.32 - $22.92 $185,644 - $297,134	12,964 Added 15.37%	97,300 $1.57 Million
Q3 2018 Nov 09, 2018	SELL	$13.03 - $21.81 $4.92 Million - $8.24 Million	-377,864 Reduced 81.75%	84,336 $1.75 Million
Q1 2017 Jan 31, 2018	BUY	N/A	462,200	462,200 $15.9 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.93B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Account

Canada Pension Plan Investment Board Acadia Pharmaceuticals Inc Transaction History